XOMA Corporation
$ 25.43
-0.44%
24 Apr - close price
- Market Cap N/A
- Current Price $ 25.43
- High / Low $ 25.50 / 25.36
- Stock P/E 25.40
- Book Value 7.07
- EPS 1.00
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.03 %
- ROE 0.34 %
- 52 Week High 26.40
- 52 Week Low 22.98
About
XOMA Corporation, a biotech royalty aggregator, discovers and develops therapeutic candidates in the United States, Europe, and Asia Pacific. The company is headquartered in Emeryville, California.
Analyst Target Price
N/A
Quarterly Earnings
| Sep 2025 | Jun 2025 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Sep 2019 | Jun 2019 | Mar 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-12 | 2025-08-13 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 |
| Reported EPS | 0.7 | 0.44 | -0.5131 | -0.3128 | -0.7031 | 1.5248 | -0.1 | -0.3264 | -0.4875 | -0.3847 | 0.2024 | -0.4667 |
| Estimated EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Surprise | 0.7 | 0.44 | -0.5131 | -0.3128 | -0.7031 | 1.5248 | -0.1 | -0.3264 | -0.4875 | -0.3847 | 0.2024 | -0.4667 |
| Surprise Percentage | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Previous Dividend Records
| Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-04-15 | 2026-01-15 | 2025-10-15 | 2025-07-15 | 2025-04-15 | 2025-01-15 | 2024-10-15 | 2024-07-15 | 2024-04-15 | 2024-01-16 |
| Amount | $0.52344 | $0.52344 | $0.52344 | $0.52344 | $0.52344 | $0.52344 | $0.52344 | $0.52344 | $0.52344 | $0.52344 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: XOMAO
2026-03-22 03:38:54
XOMA Royalty Corporation (NASDAQ:XOMA) has received a consensus "Hold" rating from six analysts, with an average 12-month target price of $61.60. Despite wide analyst divergence in price targets, the company recently reported an earnings beat with EPS of $0.12 and revenue of $13.76 million, although analysts still project a negative EPS for the current fiscal year. The stock currently trades around $28.71, with institutional ownership at a high 95.92%.
2026-03-20 03:38:54
XOMA Royalty Corporation reported strong fourth-quarter financial results, beating analyst expectations for both earnings per share and revenue. The company also highlighted significant future catalysts, with 14 programs in registrational studies and several regulatory updates and late-stage clinical readouts anticipated in 2026. Following the announcement, XOMA shares saw a significant increase in trading.
2026-03-19 10:39:27
XOMA Corp's 8.375% DP PFD B (XOMAO) has declared a dividend of $0.5234 per share. This financial announcement is a key piece of information for investors holding or considering shares in the company's preferred stock.
2026-03-19 01:09:40
XOMA Royalty Corporation reported a strong financial year in 2025, with total GAAP income and revenue of $52.1 million, a significant increase from 2024. The company saw a 68% growth in royalty receipts and returned $16 million to shareholders through buybacks, achieving a GAAP net income of $31.7 million. XOMA expanded its portfolio with 22 new assets and strategic transactions, anticipating continued growth in royalty receipts from key products and aiming for operational cash flow positivity from royalties by 2027.
2026-03-19 01:08:41
XOMA Corp reported a strong Q4 2025, with EPS of $0.26 and revenue of $13.76 million, significantly surpassing analyst forecasts. This strong financial performance, driven by growth in royalty receipts and strategic capital deployment, led to a 5.19% increase in pre-market stock price. The company projects continued growth for 2026 and aims to become cash flow positive from operations, focusing on diversifying its portfolio and maintaining disciplined capital allocation.
2026-03-18 20:38:52
Xoma Royalty reported total revenues of $52.1 million in 2025, driven by its strategic shift to royalty aggregation and significant acquisitions. The company returned to profitability with a net income of $31.7 million, reversing a prior-year loss. Key commercial drivers included royalty and milestone receipts from VABYSMO and OJEMDA.
